E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice.
about
Identification of a novel slow-muscle-fiber enhancer binding protein, MusTRD1Upstream stimulatory factor represses the induction of carnitine palmitoyltransferase-Ibeta expression by PGC-1Characterization of general transcription factor 3, a transcription factor involved in slow muscle-specific gene expressionAAV-mediated overexpression of human α7 integrin leads to histological and functional improvement in dystrophic miceDown-regulation of MyoD by calpain 3 promotes generation of reserve cells in C2C12 myoblastsQuantitative proteomic identification of six4 as the trex-binding factor in the muscle creatine kinase enhancerQuantitative proteomic identification of MAZ as a transcriptional regulator of muscle-specific genes in skeletal and cardiac myocytesIncreased glycogen accumulation in transgenic mice overexpressing glycogen synthase in skeletal muscleAAV1.NT-3 gene therapy for charcot-marie-tooth neuropathy.Laryngeal muscle surface receptors identified using random phage library.Fiber-type-specific transcription of the troponin I slow gene is regulated by multiple elementsKLF3 regulates muscle-specific gene expression and synergizes with serum response factor on KLF binding sitesInclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle.Adenovirus mediated gene transfer to skeletal muscle.Differentiation and fiber type-specific activity of a muscle creatine kinase intronic enhancerMolecular regulation of individual skeletal muscle fibre types.A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber typeAdeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model.Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic miceGene therapy for muscular dystrophy: lessons learned and path forwardNon-passaged muscle precursor cells from 32-month old rat skeletal muscle have delayed proliferation and differentiation.Treatment of hypophosphatasia by muscle-directed expression of bone-targeted alkaline phosphatase via self-complementary AAV8 vector.Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart.Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy.S. macrurus myogenic regulatory factors (MRFs) induce mammalian skeletal muscle differentiation; evidence for functional conservation of MRFs.Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle.Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunctionPlasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery.AAV-directed muscular dystrophy gene therapy.Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice.The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy.An adeno-associated virus vector efficiently and specifically transduces mouse skeletal muscle.Hypertrophy and transcriptional regulation induced in myogenic cell line L6-C5 by an increase of extracellular calcium.Mouse dystrophin enhancer preferentially targets lacZ expression in skeletal and cardiac muscle.Analysis of the inhibition of MyoD activity by ITF-2B and full-length E12/E47.β-Sarcoglycan gene transfer decreases fibrosis and restores force in LGMD2E mice.Human α7 Integrin Gene (ITGA7) Delivered by Adeno-Associated Virus Extends Survival of Severely Affected Dystrophin/Utrophin-Deficient MiceConstruction and analysis of compact muscle-specific promoters for AAV vectors.Partial rescue of growth failure in growth hormone (GH)-deficient mice by a single injection of a double-stranded adeno-associated viral vector expressing the GH gene driven by a muscle-specific regulatory cassette.Limb-girdle muscular dystrophy type 2D gene therapy restores alpha-sarcoglycan and associated proteins.
P2860
Q22003970-07B13B9B-FB06-4266-9538-7DAB06E4E943Q28213001-833520C4-A770-4484-A7D9-4DB0EA2BD266Q28217145-F13BC2BE-09FC-4173-8539-995E0EA59B54Q28283362-088ABE4B-1C25-400F-8D22-451EE013985EQ28512068-D69FEBEA-57E7-41D9-ADF5-9EE936A4D59AQ28589304-14300E9B-1D86-40FE-B68A-6DF27A9E9415Q28592770-091A72F1-EA59-4098-91AC-23F7C0F8257BQ30453888-F0B37884-D437-45AA-BBD5-D15A9B99E0E0Q30573515-8E33ACC2-ECC3-49EF-98A0-54FA6C397F46Q33228227-CFA41051-F528-43C8-B568-C603FF1201E4Q33957173-037A134D-01A0-4F5A-A670-5E29F6AC6F07Q33963844-DA838696-33C8-4938-8FC2-8875FB8BF1B4Q34029128-A6C2C580-01D9-462D-9119-0FE36DCDA79DQ34733229-8A69D03A-836B-49CD-822F-1609043503A1Q35167424-C933AECE-42B8-4F3A-8B86-AADF5CF824D1Q35178611-C7D0B88E-3CD5-45FE-BDE1-4FF909567849Q35207780-98A2CBC9-2E1B-42CF-8910-A260994A2684Q35573761-59FFCF68-8101-42DD-8D13-775580FD64C9Q36381102-A0121E90-4275-4520-8B68-09E94AE05CBDQ36382790-BF5D6452-F913-433D-8C58-53810CABF5B5Q36518148-549AAB61-59A5-4B27-9A14-251376B1192AQ36538166-D2651A2A-B3CB-4D82-A636-C9348EB08A68Q36968864-FA4B6579-D720-4F8E-8F4A-DE1B5DDF79E6Q37161996-9EA164E7-3431-4C6D-B1C4-A0C1FC4B9582Q37263839-A490C448-2728-4AFF-83B2-DFD00EFFE95BQ37400702-ED3E0A32-E695-4A5D-B00F-864FC221D4CFQ37467718-26D4C083-1A55-441D-A76D-2CF00C508328Q37562066-B9FDB96A-C21A-470E-8281-9188EF137A78Q37687423-A68DE3B6-A45A-44F7-AB00-8A4B61FC2F59Q39280475-09159466-A979-445B-895E-63117CB7E593Q39511306-4764F87C-1EE8-4085-948A-DC3A2C7A20A5Q39613077-B82B639D-1F1E-45A8-BB3D-8A4333AA77FEQ40511652-1C3BA4C8-22FE-4AE4-A3E9-EED83D753868Q40735023-B68F1026-C9BC-4DBD-8A30-B2AF1770ED74Q40876633-9C48B1A1-F8D8-47DA-A92B-EC6A1429E8DEQ41544464-7AF06A24-1DB4-4D5F-980D-A1F0C69827A5Q41668084-2F310819-60E0-4C30-A02D-F0886C432F67Q42437569-623B972B-0131-4D52-9345-B9B5937510D9Q42590798-49821637-3CFB-44AB-BC7D-CD56DC058781Q43268180-C13768B6-9B9D-46E9-A610-BB324294C398
P2860
E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
E-box sites and a proximal reg ...... iac muscle of transgenic mice.
@ast
E-box sites and a proximal reg ...... iac muscle of transgenic mice.
@en
type
label
E-box sites and a proximal reg ...... iac muscle of transgenic mice.
@ast
E-box sites and a proximal reg ...... iac muscle of transgenic mice.
@en
prefLabel
E-box sites and a proximal reg ...... iac muscle of transgenic mice.
@ast
E-box sites and a proximal reg ...... iac muscle of transgenic mice.
@en
P2093
P2860
P356
P1476
E-box sites and a proximal reg ...... iac muscle of transgenic mice.
@en
P2093
H S Haugen
M A Shield
S D Hauschka
P2860
P304
P356
10.1128/MCB.16.9.5058
P407
P577
1996-09-01T00:00:00Z